Delta Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Delta Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$993	Hold	2	–	–	﹤0.01%	569
2026 Q1	$893	Hold	2	–	–	﹤0.01%	565
2025 Q4	$907	Hold	2	–	–	﹤0.01%	570
2025 Q3	$783	Hold	2	–	–	﹤0.01%	582
2025 Q2	$890	Hold	2	–	–	﹤0.01%	566
2025 Q1	$970	Hold	2	–	–	﹤0.01%	569
2024 Q4	$805	Hold	2	–	–	﹤0.01%	584
2024 Q3	$930	Hold	2	–	–	﹤0.01%	584
2024 Q2	$937	Hold	2	–	–	﹤0.01%	592
2024 Q1	$836	Hold	2	–	–	﹤0.01%	610
2023 Q4	$814	Buy	+2	New	+$739	﹤0.01%	623

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Delta Asset Management's VRTX Position: Q2 2026 in Review

Delta Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 2 shares worth $993. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Delta Asset Management first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Delta Asset Management held 2 shares of Vertex Pharmaceuticals worth $993 as of Q2 2026.
Delta Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Delta Asset Management's portfolio in Q2 2026, its #569 holding.
Delta Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.